Gold Coast, Australia (January 3, 2020): The results of a randomized, placebo-controlled, double-blind clinical  trial of perispinal etanercept were published today, confirming the efficacy and remarkable results of perispinal etanercept in a cohort of stroke survivors with relentless, intractable daily pain after stroke. The individuals were treated an average of about 4 years after stroke and each reported constant daily pain after their stroke that had failed to adequately respond to all previous forms of treatment. They received two doses of perispinal etanercept, each two weeks apart, with the control group receiving two doses of saline administered perispinally. The control group had no change in their daily pain, but the etanercept group had a significant reduction in pain, measured at 30 days, with 30% of the etanercept patients showing near complete pain abatement after the first etanercept treatment. The study concludes: “Perispinal etanercept can provide significant and ongoing benefits for the chronic post-stroke management of pain and greater shoulder flexion by the paretic arm. Effects are rapid and highly significant, supporting direct action on brain function.”

The clinical trial results published on January 3, 2020 in the journal  Expert Opinion on Investigational Drugs. Learn More.

Immediate neurological recovery after treatment at the INR Boca Raton, August 13, 2018

Immediate neurological recovery after treatment at the INR Boca Raton, August 13, 2018, two years after a brainstem stroke. Improvements noted in chronic post-stroke pain, visual tracking and gait within minutes after treatment.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid Improvement in Walking, Balance, Tone & Cognition 3 Years After Stroke

From Kentucky to the INR in Boca Raton, Florida. Published July 16, 2018.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

From Glascow, Scotland, 1 week after treatment at the INR in Boca Raton, Florida, filmed in March 2018. Discussion with Edward Tobinick MD. Treatment was performed 8 years after stroke that caused intractable aphasia, hearing and sensory dysfunction and difficulty using the right hand (motor dysfunction) prior to treatment. A graphic illustration suggesting that chronic neuroinflammation, mediated by excess TNF in the brain, can reversibly inactivate brain circuits necessary for optimal brain function and connectivity.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Walking without a stick (cane) after treatment at the INR! Eddie and his family from Scotland, visiting the INR Boca Raton, on April 23, 2018.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Patient and father, from Iceland, discusses improvements 2 years after stroke. The stroke happened at age 17. Improvements discussed include: spasticity, left neglect, walking, speech, fatigue, and improved ability to swallow.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Treatment at the Institute of Neurological Recovery in Boca Raton, Florida, March 6, 2018, twenty two months after stroke. Immediate improvements in aphasia, apraxia of speech, walking, etc.

Request a consultation today | Terms of Use & Disclaimer

Click here to see Part 1.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use